Search results
What's the Difference Between Ozempic and Metformin, and Which One Is Right for You?
Parade via Yahoo News· 5 hours agoParticipants lost an average of nearly 15% of their body weight after 68 weeks in trials for the...
Novo Nordisk's Ozempic sales double to $700 M in China, driven by weight-loss demand | Invezz
Invezz· 6 hours agoLast year, Novo Nordisk, the Danish pharmaceutical giant, witnessed a significant surge in the sales...
Ozempic and Wegovy could soon be challenged by China’s generic competitors
Fast Company Magazine· 6 hours agoNovo Nordisk is facing the prospect of intensifying competition in the promising Chinese market...
Millions of Americans need drugs like Ozempic: Will it bankrupt the health care system?
Medical Xpress· 6 days agoAn April 24 letter from Vermont Sen. Bernie Sanders to the CEO of Novo Nordisk began with heartfelt...
In China, weight-loss drugs are becoming big business
Al Jazeera· 16 hours agoOzempic is big business in China. Last year, the Danish pharmaceutical giant Novo Nordisk doubled...
Are weight-loss drugs the future of medicine? Here's what KC-area experts had to say
KSHB-TV Kansas City· 7 days agoA new class of drugs have taken over the market: some treat type 2 diabetes, and some focus on weight loss. Semaglutide (commonly known as Ozempic or Wegovy) and Tirzepatide ...
William Blair Commentary: Waistlines and GLP1-s--Expanding in Unison
GuruFocus.com via Yahoo Finance· 2 days agoAnd what about continuous glucose monitors and insulins pumps for diabetes patients? Increased usage...
Study Raises Concerns About Rising Cost of Diabetes Meds
Medscape· 7 days agoDriven by payments for diabetes treatments — especially insulin — prescription drugs for metabolic...
CSPC Pharma Weighs Up Diet Drug For Bigger Bottom Line - CSPC Pharma Gr (OTC:CSPCY), Novo Nordisk...
Benzinga· 1 day agoIt can already fill pharmacy shelves with a wide range of approved drugs for the treatment of...
Doctors' Tips for Accessing Costly GLP-1 Therapies
Medscape· 4 days agoPhysicians must have nuanced discussions with patients about how to afford the high-cost treatments as they increase in popularity, Davisson said. "We...